What can we learn from COVID-19 to address other healthcare challenges?
12/10/22 • 32 min
Join Dr Ellie Cannon as she talks to Susan Rienow, Country President at Pfizer UK (at time of recording) and Dr Richard Torbett, CEO of the Association of the British Pharmaceutical Industry, about the lessons learnt from the COVID-19 pandemic and how this could be applied to address other major healthcare challenges.
PP-UNP-GBR-10858 / November 2024
Join Dr Ellie Cannon as she talks to Susan Rienow, Country President at Pfizer UK (at time of recording) and Dr Richard Torbett, CEO of the Association of the British Pharmaceutical Industry, about the lessons learnt from the COVID-19 pandemic and how this could be applied to address other major healthcare challenges.
PP-UNP-GBR-10858 / November 2024
Next Episode
Meeting the challenge of Antimicrobial Resistance (AMR)
Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK (at time of recording), to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society.
PP-UNP-GBR-11741 / March 2025
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/breakthroughs-373845/what-can-we-learn-from-covid-19-to-address-other-healthcare-challenges-53538649"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to what can we learn from covid-19 to address other healthcare challenges? on goodpods" style="width: 225px" /> </a>
Copy